The Extracellular RNA Communication Consortium (ERCC) is an NIH Common Fund program launched in 2013 to study extracellular RNA (exRNA). The first phase of the project focused on exRNA biology and their potential use in diagnosis and treatment of a variety of diseases. A second phase initiated in 2019 sought to develop new and improved technologies to identify, characterize, and isolate exRNA and carriers, such as extracellular vesicles and RNA binding proteins (RBPs). The ERCC is now coming to a close and will host its final meeting (ERCC19) on May 1-2, 2023. It will be free to attend and open to the public.

We encourage you to join in person at the Bethesda North Marriott in the Washington, DC area. There will also be a virtual option for those unable to attend in person. ERCC19 will emphasize the work ERCC2 researchers have done over the last four years developing technologies for characterization of single EVs, exRNA carriers, and their cargo but will also include non-ERCC researchers who are pioneers in the field. 

The ERCC has published over 800 papers related to exRNA biology and technology since project incept in 2013. The consortium has also hosted 35+ webinars and 120+ blogs and is developing an exRNA-themed online course. To stay abreast of ERCC19 announcements, we encourage you to follow @exRNA on Twitter and sign up for our email notifications.

Learn more here: https://exRNA.org/ERCC19